We started work on a theme around distributed clinical trials after listening to a really interesting presentation at the What's Next for Health Care conference hosted by Matthew Holt and Jessica DaMassa. One presentation, moderated by Craig Lipset from the Decentralized Trials and Research Alliance, featured a very interesting panel, including Christine Lemke from Evidation. Ms Lemke's comments were particularly noteworthy on the topics of Real World Evidence, synthetic controls and how all those nifty remote monitoring devices may play a significant role in separating clinical trials from the medical research centers in the U.S.
Aside from being more convenient and less expensive, decentralized clinical trials provide some hope that trial subjects will diversify away from the most common demographic - middle-age to older white men - and look at research questions that have been difficult to answer for lack of willing subjects.
Who better to walk through the implications of such a significant change in how trials might change and what it means for health care than our friend, Marcus Whitney, co-founder of Jumpstart Health Investors and founder and General Partner of Jumpstart Nova, the first Black healthcare venture fund in America, launched in 2020.
Please join us:
|
Wednesday, October 13th @ 10am CT (add to Outlook Calendar) Connection Details: Health Policy/Unplugged Subscribers CLICK HERE for event details (includes video and materials link) (For uncooperative browsers, cut and paste: https://app.hedgeye.com/feed_items/105829?with_category=48-health-policy) |
Topics:
- Policy shifts, From funding research at non-traditional locations like HBCUs; to mandating representation by certain populations; to acceptance of Real World Evidence at the FDA like HBCUs, policy is directing research entities to new and different ways of conducting trials.
- Genetic Data. One solution advocated by ME and others seeks to deploy genetic data to make trials faster and more diverse.
- EHR Records. Clinical data with a longitudinal record to create a synthetic control arm, a huge time and expense saver.
- Remote Patient Monitoring. Enroll people in a remote monitoring study where you make available glucose monitors, heart, BP, etc. across a study population to collect “real world evidence” relevant to the study.
- Approaches of IQVA and LH
- Impacts on traditional CROs like CRL
We look forward to you joining us.
About Marcus Whitney:
Marcus is a self-taught software developer, entrepreneur, and venture capitalist with a track record of success in all areas.
Prior to co-founding Jumpstart Health Investors, he was the Director of Technology and Partner at Emma Email Marketing, acquired by Campaign Monitor, and Co-Founder at Clariture Health, a HIPAA compliant digital ad management platform, acquired by Trilliant Health.
Marcus is the founder and General Partner of Jumpstart Nova, the first Black healthcare venture fund in America, launched in 2020 to make seed and Series A investments in promising Black-led healthcare companies. Marcus was the founder and CEO of the Health:Further conference, which operated from 2015-2018, adding thousands of leaders in health innovation from around the country to Jumpstart Health Investors' network. As Founding Partner of Jumpstart Health Investors, Marcus was the initial architect of the algorithm used to score over one thousand early-stage healthcare companies for consideration by Jumpstart Foundry, the firm's pre-seed index fund.
Marcus has made his mark on the city of Nashville through a variety of avenues. Marcus brought professional soccer to the city as co-founder and minority owner of Major League Soccer team, Nashville Soccer Club. Marcus is also a member of the board of the Country Music Hall of Fame® and Museum, the Nashville Convention and Visitors Corporation, and Launch Tennessee.
Marcus is the author of the Amazon #1 best-selling book "Create and Orchestrate", about claiming your Creative Power through entrepreneurship. Marcus has been featured by Entrepreneur, CNBC, Inc., NPR, Fast Company, and The Atlantic.
Emily Evans
Managing Director – Health Policy
Twitter
LinkedIn
